This week on Careers in Discovery, we sat down with Marco Schmidt, CSO of biotx.ai, to talk about AI, Biotech, and the future of drug discovery.

Marco’s career has taken him from Biochemistry to Biotech start-ups, where he’s using causal inference to reshape clinical trials and drug development. We explored the evolution of AI in science, the rise of tech-bio companies, and why he believes this is the best time in history to be a scientist.

We also got into the mindset shift needed for scientists moving into business - and why failure isn’t just inevitable, but essential.

Join us for a really thought-provoking episode.